Lenalidomide with rituximab for mantle cell lymphoma
11 Dec 2017
Lenalidomide with rituximab for mantle cell lymphoma
Combination chemotherapy for multiple myeloma
Results of the AML 12 trial
Why we are not ready for personalised medicine
Genetically profiling entire populations, starting with Estonia
Neuroblastoma and cell communication networks
Personalised medicine differs from precision medicine
Approaches to screening and early detection across Europe
Connecting personalised medicine research in Canada with Europe
Cancer Core Europe
Roche joining forces to forward precision oncology
Effective implementation of personalised medicine guidelines